These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32217112)

  • 21. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness Analysis of Radiofrequency Ablation in Patients With Barrett Esophagus and High-grade Dysplasia or Low-grade Dysplasia.
    Federici C; Callea G; Testoni PA; Costamagna G; Trentino P; Repici A
    Clin Ther; 2023 May; 45(5):426-436. PubMed ID: 37137786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial.
    van Vilsteren FG; Pouw RE; Seewald S; Alvarez Herrero L; Sondermeijer CM; Visser M; Ten Kate FJ; Yu Kim Teng KC; Soehendra N; Rösch T; Weusten BL; Bergman JJ
    Gut; 2011 Jun; 60(6):765-73. PubMed ID: 21209124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry.
    Haidry RJ; Dunn JM; Butt MA; Burnell MG; Gupta A; Green S; Miah H; Smart HL; Bhandari P; Smith LA; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Novelli M; Banks MR; Lovat LB
    Gastroenterology; 2013 Jul; 145(1):87-95. PubMed ID: 23542069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or stage T1 adenocarcinoma in Barrett's esophagus: a randomized pilot study (BRIDE).
    Peerally MF; Bhandari P; Ragunath K; Barr H; Stokes C; Haidry R; Lovat L; Smart H; Harrison R; Smith K; Morris T; de Caestecker JS
    Gastrointest Endosc; 2019 Apr; 89(4):680-689. PubMed ID: 30076843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage cryotherapy after failed radiofrequency ablation for Barrett's esophagus-related dysplasia is safe and effective.
    Sengupta N; Ketwaroo GA; Bak DM; Kedar V; Chuttani R; Berzin TM; Sawhney MS; Pleskow DK
    Gastrointest Endosc; 2015 Sep; 82(3):443-8. PubMed ID: 25887715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced esophageal cancer in patients who underwent radiofrequency ablation for barrett esophagus with high-grade dysplasia.
    Kim MP; Brown KN; Schwartz MR; Blackmon SH
    Innovations (Phila); 2013; 8(1):17-22. PubMed ID: 23571789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.
    Cotton CC; Haidry R; Thrift AP; Lovat L; Shaheen NJ
    Gastroenterology; 2018 Aug; 155(2):316-326.e6. PubMed ID: 29655833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance After Treatment of Barrett's Esophagus Benefits Those With High-Grade Dysplasia or Intramucosal Cancer Most.
    Cotton CC; Shaheen NJ; Thrift AP
    Am J Gastroenterol; 2022 Jul; 117(7):1056-1062. PubMed ID: 35435856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
    Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
    Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial.
    Phoa KN; van Vilsteren FG; Weusten BL; Bisschops R; Schoon EJ; Ragunath K; Fullarton G; Di Pietro M; Ravi N; Visser M; Offerhaus GJ; Seldenrijk CA; Meijer SL; ten Kate FJ; Tijssen JG; Bergman JJ
    JAMA; 2014 Mar; 311(12):1209-17. PubMed ID: 24668102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia.
    Pouw RE; Wirths K; Eisendrath P; Sondermeijer CM; Ten Kate FJ; Fockens P; Devière J; Neuhaus H; Bergman JJ
    Clin Gastroenterol Hepatol; 2010 Jan; 8(1):23-9. PubMed ID: 19602454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent confirmed low-grade dysplasia in Barrett's esophagus is a risk factor for progression to high-grade dysplasia and adenocarcinoma in a US Veterans cohort.
    Song KY; Henn AJ; Gravely AA; Mesa H; Sultan S; Shaheen NJ; Shaukat A; Hanson BJ
    Dis Esophagus; 2020 Mar; 33(2):. PubMed ID: 31274147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia: results from a randomized controlled trial (SURF trial).
    Phoa KN; Rosmolen WD; Weusten BLAM; Bisschops R; Schoon EJ; Das S; Ragunath K; Fullarton G; DiPietro M; Ravi N; Tijssen JGP; Dijkgraaf MGW; Bergman JJGHM;
    Gastrointest Endosc; 2017 Jul; 86(1):120-129.e2. PubMed ID: 27956164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease Progression in Barrett's Low-Grade Dysplasia With Radiofrequency Ablation Compared With Surveillance: Systematic Review and Meta-Analysis.
    Qumseya BJ; Wani S; Gendy S; Harnke B; Bergman JJ; Wolfsen H
    Am J Gastroenterol; 2017 Jun; 112(6):849-865. PubMed ID: 28374819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent indefinite for dysplasia in Barrett's esophagus is a risk factor for dysplastic progression to low-grade dysplasia.
    Henn AJ; Song KY; Gravely AA; Mesa H; Sultan S; Shaheen NJ; Shaukat A; Hanson BJ
    Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32399569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry.
    Ganz RA; Overholt BF; Sharma VK; Fleischer DE; Shaheen NJ; Lightdale CJ; Freeman SR; Pruitt RE; Urayama SM; Gress F; Pavey DA; Branch MS; Savides TJ; Chang KJ; Muthusamy VR; Bohorfoush AG; Pace SC; DeMeester SR; Eysselein VE; Panjehpour M; Triadafilopoulos G;
    Gastrointest Endosc; 2008 Jul; 68(1):35-40. PubMed ID: 18355819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of low-grade dysplasia in Barrett's esophagus.
    Wani S
    Curr Opin Gastroenterol; 2012 Jul; 28(4):370-6. PubMed ID: 22508323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiofrequency Ablation in Patients with Barrett's Esophagus- related Neoplasia - Long-Term Outcomes in the Czech National Database.
    Krajciova J; Janicko M; Falt P; Gregar J; Suchanek S; Ngo O; Kollar M; Urban O; Prochazka V; Zavoral M; Spicak J; Martinek J
    J Gastrointestin Liver Dis; 2019 Jun; 28():149-155. PubMed ID: 31204400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cost-utility analysis of ablative therapy for Barrett's esophagus.
    Inadomi JM; Somsouk M; Madanick RD; Thomas JP; Shaheen NJ
    Gastroenterology; 2009 Jun; 136(7):2101-2114.e1-6. PubMed ID: 19272389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.